ARWR

NASDAQ HEALTHCARE

Arrowhead Pharmaceuticals Inc

$86.76

$0.54 (+0.63%)

Live quote

52w: $15.01 – $95.49

Loading chart…

P/E Ratio—

P/B Ratio19.78

EV/EBITDA—

Debt/Equity—

ROE-0.27%

ROIC—

Revenue Growth23258.15%

Gross Margin—

Arrowhead Pharmaceuticals, Inc. develops drugs for the treatment of intractable diseases in the United States. The company is headquartered in Pasadena, California.

Own ARWR? Track it here.

Create a free account to add ARWR to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account